Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway

Fig. 1

The expression of miR-29c was reduced in breast cancers and was positively correlated with the survival rate of breast cancer patients. a The expression of miR-29c in normal tissues and breast cancer tissues was checked by qRT-PCR. b The expressions of miR-29c in the serum of normal controls and breast cancer patients at different stages were evaluated by qRT-PCR. c Kaplan-Meier analysis of overall survival curves for breast cancer patients with low versus high expressions of miR-29. Data were presented as mean ± SD, ***P < 0.001

Back to article page